Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06457802 · ClinicalTrials.gov registry record · NA

Sit Less Program for Patients With Type 2 Diabetes

A NA study, sponsored by Vanderbilt University.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT06457802 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06457802, a NA study, was terminated before completion, sponsored by Vanderbilt University.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This randomized controlled trial aims to evaluate an 8-week intervention designed to reduce sedentary behavior (SB) in patients with type 2 diabetes (T2D) using wearable technology. The intervention involves the use of Fitbit devices to prompt standing/walking breaks, a smart water bottle to encourage hydration-related movement, and tailored text messages for behavior reinforcement. Participants will be assessed at baseline and post-intervention for changes in SB, light physical activity, cardiometabolic markers, and patient-centered outcomes. The study seeks to determine the intervention's acceptability and preliminary efficacy in reducing SB and improving health outcomes in T2D patients.

Interventions

  • BEHAVIORAL Sit Less Program

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2024-06-12
Est. Completion 2024-08-20
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT06457802

The ClinicalTrials.gov registry entry for NCT06457802 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Sit Less Program is the first listed.

NCT06457802 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06457802 about?

NCT06457802 is a clinical study titled "Sit Less Program for Patients With Type 2 Diabetes". This randomized controlled trial aims to evaluate an 8-week intervention designed to reduce sedentary behavior (SB) in patients with type 2 diabetes (T2D) using wearable technology. The intervention involves the use of Fitbit devices to prompt standing/walking breaks, a smart water bottle to encoura...

What is the current status of trial NCT06457802?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2024-06-12. Estimated completion is 2024-08-20.

What interventions are being tested in trial NCT06457802?

The interventions under investigation include: Sit Less Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06457802?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.